[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

United States Thalidomide Market Research Report Forecast 2017-2021

May 2017 | 102 pages | ID: U972BB3DB1EEN
S&P Consulting

US$ 2,960.00 US$ 3,700.00 -20 %

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The United States Thalidomide Market Research Report Forecast 2017-2021 is a valuable source of insightful data for business strategists. It provides the Thalidomide industry overview with growth analysis and historical & futuristic cost, revenue, demand and supply data (as applicable). The research analysts provide an elaborate description of the value chain and its distributor analysis. This Thalidomide market study provides comprehensive data which enhances the understanding, scope and application of this report.

This report provides comprehensive analysis of
  • Key market segments and sub-segments
  • Evolving market trends and dynamics
  • Changing supply and demand scenarios
  • Quantifying market opportunities through market sizing and market forecasting
  • Tracking current trends/opportunities/challenges
  • Competitive insights
  • Opportunity mapping in terms of technological breakthroughs
The Major players reported in the market include:

Pfizer
Allergan
Alnylam Pharmaceuticals
Five Prime Therapeutics
Angstrom Pharmaceuticals
Acceleron Pharma
Biocon
Enzon Pharmaceuticals
CASI Pharmaceuticals

United States Thalidomide Market: Product Segment Analysis
  • Type 1
  • Type 2
  • Type 3
United States Thalidomide Market: Application Segment Analysis
  • Application 1
  • Application 2
  • Application 3
Reasons for Buying this Report
  • This report provides pin-point analysis for changing competitive dynamics
  • It provides a forward looking perspective on different factors driving or restraining market growth
  • It provides a six-year forecast assessed on the basis of how the market is predicted to grow
  • It helps in understanding the key product segments and their future
  • It provides pin point analysis of changing competition dynamics and keeps you ahead of competitors
  • It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments
CHAPTER 1 THALIDOMIDE MARKET OVERVIEW

1.1 Product Overview and Scope of Thalidomide
1.2 Thalidomide Market Segmentation by Type
  1.2.1 United States Production Market Share of Thalidomide by Type in 2015
  1.2.1 Type
  1.2.2 Type
  1.2.3 Type
1.3 Thalidomide Market Segmentation by Application
  1.3.1 Thalidomide Consumption Market Share by Application in 2015
  1.3.2 Application
  1.3.3 Application
  1.3.4 Application
1.4 United States Market Size Sales (Value) and Revenue (Volume) of Thalidomide (2011-2021)

CHAPTER 2 UNITED STATES ECONOMIC IMPACT ON THALIDOMIDE INDUSTRY

2.1 United States Macroeconomic Analysis
2.2 United States Macroeconomic Environment Development Trend

CHAPTER 3 UNITED STATES THALIDOMIDE MARKET COMPETITION BY MANUFACTURERS

3.1 United States Thalidomide Production and Share by Manufacturers (2015 and 2016)
3.2 United States Thalidomide Revenue and Share by Manufacturers (2015 and 2016)
3.3 United States Thalidomide Average Price by Manufacturers (2015 and 2016)
3.4 Manufacturers Thalidomide Manufacturing Base Distribution, Production Area and Product Type
3.5 Thalidomide Market Competitive Situation and Trends
  3.5.1 Thalidomide Market Concentration Rate
  3.5.2 Thalidomide Market Share of Top 3 and Top 5 Manufacturers
  3.5.3 Mergers & Acquisitions, Expansion

CHAPTER 4 UNITED STATES THALIDOMIDE PRODUCTION, REVENUE (VALUE), PRICE TREND BY TYPE

4.1 United States Thalidomide Production and Market Share by Type (2012-2017)
4.2 United States Thalidomide Revenue and Market Share by Type (2012-2017)
4.3 United States Thalidomide Price by Type (2012-2017)
4.4 United States Thalidomide Production Growth by Type (2012-2017)

CHAPTER 5 UNITED STATES THALIDOMIDE MARKET ANALYSIS BY APPLICATION

5.1 United States Thalidomide Consumption and Market Share by Application (2012-2017)
5.2 United States Thalidomide Consumption Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities
  5.3.1 Potential Applications
  5.3.2 Emerging Markets/Countries

CHAPTER 6 UNITED STATES THALIDOMIDE MANUFACTURERS ANALYSIS

6.1 Pfizer
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Product Type, Application and Specification
  6.1.3 Production, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Business Overview
6.2 Allergan
  6.2.1 Company Basic Information, Manufacturing Base and Competitors
  6.2.2 Product Type, Application and Specification
  6.2.3 Production, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Business Overview
6.3 Alnylam Pharmaceuticals
  6.3.1 Company Basic Information, Manufacturing Base and Competitors
  6.3.2 Product Type, Application and Specification
  6.3.3 Production, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Business Overview
6.4 Five Prime Therapeutics
  6.4.1 Company Basic Information, Manufacturing Base and Competitors
  6.4.2 Product Type, Application and Specification
  6.4.3 Production, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Business Overview
6.5 Angstrom Pharmaceuticals
  6.5.1 Company Basic Information, Manufacturing Base and Competitors
  6.5.2 Product Type, Application and Specification
  6.5.3 Production, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Business Overview
6.6 Acceleron Pharma
  6.6.1 Company Basic Information, Manufacturing Base and Competitors
  6.6.2 Product Type, Application and Specification
  6.6.3 Production, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Business Overview
6.7 Biocon
  6.7.1 Company Basic Information, Manufacturing Base and Competitors
  6.7.2 Product Type, Application and Specification
  6.7.3 Production, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Business Overview
6.8 Enzon Pharmaceuticals
  6.6.1 Company Basic Information, Manufacturing Base and Competitors
  6.6.2 Product Type, Application and Specification
  6.6.3 Production, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Business Overview
6.9 CASI Pharmaceuticals
  6.9.1 Company Basic Information, Manufacturing Base and Competitors
  6.9.2 Product Type, Application and Specification
  6.9.3 Production, Revenue, Price and Gross Margin (2012-2017)
  6.9.4 Business Overview

CHAPTER 7 THALIDOMIDE MANUFACTURING COST ANALYSIS

7.1 Thalidomide Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Thalidomide

CHAPTER 8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Thalidomide Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Thalidomide Major Manufacturers in 2015
8.4 Downstream Buyers

CHAPTER 9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

CHAPTER 10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

CHAPTER 11 UNITED STATES THALIDOMIDE MARKET FORECAST (2017-2021)

11.1 United States Thalidomide Production, Revenue Forecast (2017-2021)
11.2 United States Thalidomide Production, Consumption Forecast by Regions (2017-2021)
11.3 United States Thalidomide Production Forecast by Type (2017-2021)
11.4 United States Thalidomide Consumption Forecast by Application (2017-2021)
11.5 Thalidomide Price Forecast (2017-2021)

CHAPTER 12 APPENDIX

LIST OF TABLES AND FIGURES

Figure Picture of Thalidomide
Table Classification of Thalidomide
Figure United States Sales Market Share of Thalidomide by Type in 2015
Table Application of Thalidomide
Figure United States Sales Market Share of Thalidomide by Application in 2015
Figure United States Thalidomide Sales and Growth Rate (2011-2021)
Figure United States Thalidomide Revenue and Growth Rate (2011-2021)
Table United States Thalidomide Sales of Key Manufacturers (2015 and 2016)
Table United States Thalidomide Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Thalidomide Sales Share by Manufacturers
Figure 2016 Thalidomide Sales Share by Manufacturers
Table United States Thalidomide Revenue by Manufacturers (2015 and 2016)
Table United States Thalidomide Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States Thalidomide Revenue Share by Manufacturers
Table 2016 United States Thalidomide Revenue Share by Manufacturers
Table United States Market Thalidomide Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market Thalidomide Average Price of Key Manufacturers in 2015
Figure Thalidomide Market Share of Top 3 Manufacturers
Figure Thalidomide Market Share of Top 5 Manufacturers
Table United States Thalidomide Sales by Type (2012-2017)
Table United States Thalidomide Sales Share by Type (2012-2017)
Figure United States Thalidomide Sales Market Share by Type in 2015
Table United States Thalidomide Revenue and Market Share by Type (2012-2017)
Table United States Thalidomide Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Thalidomide by Type (2012-2017)
Table United States Thalidomide Price by Type (2012-2017)
Figure United States Thalidomide Sales Growth Rate by Type (2012-2017)
Table United States Thalidomide Sales by Application (2012-2017)
Table United States Thalidomide Sales Market Share by Application (2012-2017)
Figure United States Thalidomide Sales Market Share by Application in 2015
Table United States Thalidomide Sales Growth Rate by Application (2012-2017)
Figure United States Thalidomide Sales Growth Rate by Application (2012-2017)
Table Pfizer Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Pfizer Thalidomide Production, Revenue, Price and Gross Margin (2012-2017)
Table Pfizer Thalidomide Market Share (2012-2017)
Table Allergan Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Allergan Thalidomide Production, Revenue, Price and Gross Margin (2012-2017)
Table Allergan Thalidomide Market Share (2012-2017)
Table Alnylam Pharmaceuticals Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Alnylam Pharmaceuticals Thalidomide Production, Revenue, Price and Gross Margin (2012-2017)
Table Alnylam Pharmaceuticals Thalidomide Market Share (2012-2017)
Table Five Prime Therapeutics Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Five Prime Therapeutics Thalidomide Production, Revenue, Price and Gross Margin (2012-2017)
Table Five Prime Therapeutics Thalidomide Market Share (2012-2017)
Table Angstrom Pharmaceuticals Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Angstrom Pharmaceuticals Thalidomide Production, Revenue, Price and Gross Margin (2012-2017)
Table Angstrom Pharmaceuticals Thalidomide Market Share (2012-2017)
Table Acceleron Pharma Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Acceleron Pharma Thalidomide Production, Revenue, Price and Gross Margin (2012-2017)
Table Acceleron Pharma Thalidomide Market Share (2012-2017)
Table Biocon Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Biocon Thalidomide Production, Revenue, Price and Gross Margin (2012-2017)
Table Biocon Thalidomide Market Share (2012-2017)
Table Enzon Pharmaceuticals Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Enzon Pharmaceuticals Thalidomide Production, Revenue, Price and Gross Margin (2012-2017)
Table Enzon Pharmaceuticals Thalidomide Market Share (2012-2017)
Table CASI Pharmaceuticals Basic Information, Manufacturing Base, Production Area and Its Competitors
Table CASI Pharmaceuticals Thalidomide Production, Revenue, Price and Gross Margin (2012-2017)
Table CASI Pharmaceuticals Thalidomide Market Share (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Thalidomide
Figure Manufacturing Process Analysis of Thalidomide
Figure Thalidomide Industrial Chain Analysis
Table Raw Materials Sources of Thalidomide Major Manufacturers in 2015
Table Major Buyers of Thalidomide
Table Distributors/Traders List
Figure United States Thalidomide Production and Growth Rate Forecast (2017-2021)
Figure United States Thalidomide Revenue and Growth Rate Forecast (2017-2021)
Table United States Thalidomide Production Forecast by Type (2017-2021)
Table United States Thalidomide Consumption Forecast by Application (2017-2021)


More Publications